We are live on ! Find out more
DNA.WS

Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS

Delisted

DNA.WS was delisted on the 3rd of September, 2024.

Back to rankings

1 hedge funds and large institutions have $1 invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

67% less capital invested

Capital invested by funds: $3 → $1 (-$2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
NC
NewSquare Capital
Pennsylvania
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
HIA
1
Harbor Investment Advisory
Maryland
$1 – – –
NC
2
NewSquare Capital
Pennsylvania
– -$1 -60 Closed

DNA.WS Hedge Fund Activity: Q3 2025 in Review

1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) for Q3 2025, worth a combined $1 — down 67% from $3 a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DNA.WS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was NewSquare Capital, exiting entirely with an estimated $1 sold.

  • 1 institutional investor held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) as of Q3 2025, down from 2 in Q2 2025.
  • Funds reported $1 of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share stock for Q3 2025, down 67% quarter-over-quarter.
  • 0 funds opened new Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share positions in Q3 2025 and 1 closed out, a net change of -1 holder.
  • The largest Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share seller in Q3 2025 was NewSquare Capital, an estimated $1 sold.

Based on aggregated 13F filings for Q3 2025.